JP2021111248A - 治験マッチング装置 - Google Patents
治験マッチング装置 Download PDFInfo
- Publication number
- JP2021111248A JP2021111248A JP2020004131A JP2020004131A JP2021111248A JP 2021111248 A JP2021111248 A JP 2021111248A JP 2020004131 A JP2020004131 A JP 2020004131A JP 2020004131 A JP2020004131 A JP 2020004131A JP 2021111248 A JP2021111248 A JP 2021111248A
- Authority
- JP
- Japan
- Prior art keywords
- clinical trial
- information
- clinical
- patient
- matching device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims abstract description 32
- 229940079593 drug Drugs 0.000 claims abstract description 31
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 230000007717 exclusion Effects 0.000 claims description 8
- 230000006870 function Effects 0.000 description 104
- 238000012545 processing Methods 0.000 description 47
- 239000002547 new drug Substances 0.000 description 32
- 201000010099 disease Diseases 0.000 description 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 24
- 229940000406 drug candidate Drugs 0.000 description 24
- 206010064571 Gene mutation Diseases 0.000 description 14
- 238000010586 diagram Methods 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 108010042653 IgA receptor Proteins 0.000 description 10
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 10
- 230000008569 process Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000004891 communication Methods 0.000 description 7
- 238000009534 blood test Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 102000001301 EGF receptor Human genes 0.000 description 5
- 108060006698 EGF receptor Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 229940126585 therapeutic drug Drugs 0.000 description 5
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 4
- 229940121647 egfr inhibitor Drugs 0.000 description 4
- 201000005202 lung cancer Diseases 0.000 description 4
- 208000020816 lung neoplasm Diseases 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 229940127557 pharmaceutical product Drugs 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000029523 Interstitial Lung disease Diseases 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
Abstract
Description
本実施形態について説明したが、上述した実施形態以外にも、種々の異なる形態にて実施されてよいものである。
100 治験マッチング装置
151 受付機能
152 検索機能
153 出力処理機能
154 収集機能
155 更新機能
Claims (7)
- 患者の情報を受け付ける受付部と、
投薬する際の条件が設定された治験と当該治験による治験結果とを対応付けるデータを複数の治験について記憶する記憶部を参照して、前記複数の治験の中から、前記患者の情報に基づいて前記患者にマッチングする治験を検索する検索部と、
前記検索した治験の情報を提示する提示部と、
前記検索した治験を、前記患者に実施したときに得られた治験結果と当該患者の臨床情報とを収集して、前記記憶部に記憶させる収集部と、
前記収集した臨床情報の中に、薬効の有意差を確認できる臨床情報が存在する場合、当該臨床情報に基づいて、前記検索した治験の前記条件を更新する更新部と、
を備える治験マッチング装置。 - 前記検索部は、前記記憶部を参照して、前記患者にマッチングする複数の治験を検索し、
前記提示部は、前記検索した複数の治験の中から1つの治験を選択させる画面と、当該治験の付帯情報としてQOL(Quality Of Life)に関する情報とを提示する、
請求項1に記載の治験マッチング装置。 - 前記収集部は、前記QOLに関する情報を含む臨床情報を収集する、
請求項2に記載の治験マッチング装置。 - 前記収集部は、遺伝子に関する情報を含む臨床情報を収集する、
請求項1〜3のいずれか一項に記載の治験マッチング装置。 - 前記収集部は、匿名化された臨床情報を収集する、
請求項1〜4のいずれか一項に記載の治験マッチング装置。 - 前記条件は、治験の実施に適格な適格基準と、当該適格基準に該当しない除外基準とを含む、
請求項1〜5のいずれか一項に記載の治験マッチング装置。 - 実施する治験の情報を受け付ける受付部と、
投薬する際の条件が設定された治験と当該治験による治験結果とを対応付けるデータを複数の治験について記憶する記憶部を参照して、複数の患者の中から、前記実施する治験の情報に基づいて前記実施する治験にマッチングする患者を検索する検索部と、
前記検索した患者の情報を提示する提示部と、
前記検索した患者に対して前記実施する治験により得られた治験結果と当該患者の臨床情報とを収集して、前記記憶部に記憶させる収集部と、
前記収集した臨床情報の中に、薬効の有意差を確認できる臨床情報が存在する場合、当該臨床情報に基づいて、前記実施する治験の前記条件を更新する更新部と、
を備える治験マッチング装置。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020004131A JP2021111248A (ja) | 2020-01-15 | 2020-01-15 | 治験マッチング装置 |
PCT/JP2021/001310 WO2021145439A1 (ja) | 2020-01-15 | 2021-01-15 | 治験マッチング装置 |
US17/588,399 US20220157412A1 (en) | 2020-01-15 | 2022-01-31 | Clinical trial matching apparatus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020004131A JP2021111248A (ja) | 2020-01-15 | 2020-01-15 | 治験マッチング装置 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2021111248A true JP2021111248A (ja) | 2021-08-02 |
Family
ID=76864455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020004131A Pending JP2021111248A (ja) | 2020-01-15 | 2020-01-15 | 治験マッチング装置 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20220157412A1 (ja) |
JP (1) | JP2021111248A (ja) |
WO (1) | WO2021145439A1 (ja) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7711580B1 (en) * | 2000-10-31 | 2010-05-04 | Emergingmed.Com | System and method for matching patients with clinical trials |
CN1636210A (zh) * | 2001-11-02 | 2005-07-06 | 美国西门子医疗解决公司 | 用于临床试验的病人数据挖掘 |
US20130332191A1 (en) * | 2012-06-06 | 2013-12-12 | Cerner Innovation, Inc. | Identifying patient eligibility for clinical trials |
JP6953270B2 (ja) * | 2017-10-19 | 2021-10-27 | キヤノンメディカルシステムズ株式会社 | 病院情報システム、及び薬剤提案選出プログラム |
-
2020
- 2020-01-15 JP JP2020004131A patent/JP2021111248A/ja active Pending
-
2021
- 2021-01-15 WO PCT/JP2021/001310 patent/WO2021145439A1/ja active Application Filing
-
2022
- 2022-01-31 US US17/588,399 patent/US20220157412A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20220157412A1 (en) | 2022-05-19 |
WO2021145439A1 (ja) | 2021-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhu et al. | Mortality and morbidity of infants born extremely preterm at tertiary medical centers in China from 2010 to 2019 | |
Sarraj et al. | Endovascular therapy for acute ischemic stroke with occlusion of the middle cerebral artery M2 segment | |
Gupta et al. | A quantitative severity scale for retinopathy of prematurity using deep learning to monitor disease regression after treatment | |
Treskes et al. | Effect of smartphone-enabled health monitoring devices vs regular follow-up on blood pressure control among patients after myocardial infarction: a randomized clinical trial | |
Pignolo et al. | The natural history of flare‐ups in fibrodysplasia ossificans progressiva (FOP): a comprehensive global assessment | |
Costei et al. | Perinatal outcome following third trimester exposure to paroxetine | |
Yanovski et al. | Treatment of pediatric and adolescent obesity | |
Riker et al. | Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients | |
Brouwer et al. | Facioscapulohumeral muscular dystrophy in early childhood | |
Mace et al. | Correlations between endoscopy score and quality of life changes after sinus surgery | |
Matsuo et al. | Minimally invasive surgery and risk of capsule rupture for women with early-stage ovarian cancer | |
Takahashi et al. | An overview of telehealth in the management of cardiovascular disease: a scientific statement from the American Heart Association | |
US20190027254A1 (en) | Medical information providing apparatus, operation method of medical information providing apparatus, and medical information providing program | |
Wang et al. | Low-dose vs standard-dose alteplase for patients with acute ischemic stroke: secondary analysis of the ENCHANTED randomized clinical trial | |
Freeman | Perinatal depression: Recommendations for prevention and the challenges of implementation | |
JP6527771B2 (ja) | 情報分析支援装置とその作動方法および作動プログラム、並びに情報分析支援システム | |
Rogers | Internet of things-based smart healthcare systems, wireless connected devices, and body sensor networks in COVID-19 remote patient monitoring | |
Zhao et al. | The influence of delayed treatment due to COVID-19 on patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy | |
Byrne et al. | Outcomes following extracorporeal membrane oxygenation for severe COVID-19 in pregnancy or post partum | |
Ullrich et al. | Coronary venous pressure and microvascular hemodynamics in patients with microvascular angina: a randomized clinical trial | |
JP2021051703A (ja) | 診療支援装置及び診療支援プログラム | |
Patil et al. | Association Between Visual Acuity and Residual Retinal Fluid Following Intravitreal Anti–Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-analysis | |
JP2011238219A (ja) | 自動医薬品処方のシステム及び方法 | |
Barbazetto et al. | A novel TIMP3 mutation associated with Sorsby fundus dystrophy | |
Jüni et al. | Allocation concealment in clinical trials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210318 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20210318 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20210318 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210825 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221215 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231219 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240216 |